Haystack Oncology, an oncology company, uses the most recent circulating tumor DNA detection technology to enhance the diagnosis of minimum residual disease and provide superior therapy decision-making information.

Health Care

Biotechnology

Haystack Oncology

Dan Edelstein

Erika Kerr

Lauren Ramgattie, MBA

The Laboratory Research and Development team at Haystack Oncology is dedicated to advancing the company's cutting-edge circulating tumor DNA detection technologies. This team conducts rigorous scientific research to develop and optimize assays, automate laboratory processes, and leverage bioinformatics to analyze complex data. Their collective expertise ensures the innovation and enhancement of diagnostic tools that improve the identification of minimum residual disease and inform therapeutic decisions for oncology patients.

Laboratory Research and Development

The Leadership Team at Haystack Oncology drives the company’s strategic vision and operational excellence in advancing cutting-edge circulating tumor DNA detection technologies. Comprising key executives with expertise in innovation, finance, technology, and management, the team focuses on enhancing diagnostic capabilities for minimum residual disease and improving therapy decision-making to ultimately better patient outcomes in oncology.

Haystack Oncology

Org chart

Teams

Laboratory Research and Development

Leadership Team

Offices

Haystack Oncology

Org chart

Teams

Laboratory Research and Development

Leadership Team

Offices

Related companies